Global /China /Healthcare /Medical Distribution /AIXN
chevron_leftBack
AiXin Life International, Inc. logo

AiXin Life International, Inc.

AIXN
OTCMKTS: AIXN Delayed
0.2030USD -19%
As of 7 June 2026, AiXin Life International, Inc. has a market cap of $5.07M USD, ranking #44431 globally and #6452 in China. It ranks #3936 in the Healthcare sector, and #196 in the Medical Distribution industry.
Global Rank
44431
Country Rank
6452
Sector Rank
3936
Industry Rank
196
Key Stats
Market Cap
$5.07MUSD
Enterprise Value
$6.27MUSD
Revenue (TTM)
$1.87MUSD
EBITDA (TTM)
-$2.73MUSD
Net Income (TTM)
-$2.86MUSD
EBITDA Margin
-146%
Profit Margin
-153%
PS Ratio
2.7
PB Ratio
-0.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Quanzhong Lin open_in_new
Employees
120
Website
aixinjituan.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-19% -19% -9.1% 21% -66% 384%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
AIXN
AiXin Life International Inc
ISIN: US0096033099
Shares Out.:
25.0M1 Shares Float: 8.581M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2030 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About AiXin Life International, Inc.

AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.

Similar Companies

Industry: Medical Distribution (China)
Name
Market Cap diff.
PE
$7.48B
58.61B HKD
147K%
7.2
$3.82B
25.88B CNY
75K%
13.3
$1.63B
11.06B CNY
32K%
31.2
$1.24B
8.37B CNY
24K%
-
$1.23B
8.31B CNY
24K%
17.9
$1.22B
8.24B CNY
24K%
35.2
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
MCK
$100.76B
2M%
24.0
COR
$60.58B
1M%
37.4
$47.73B
940K%
29.6
HSIC
$8.47B
167K%
22.6
GALE
$5.32B
4.2B CHF
105K%
23.0
DKSH
$4.85B
3.83B CHF
95K%
18.9
chevron_leftBack